Skip to main content
. 2019 Jul 8;39(7):BSR20180551. doi: 10.1042/BSR20180551

Figure 3. LIFR-AS1 inhibits breast cancer cell migration and invasion.

Figure 3

(A) Breast cancer cell migration was analyzed by wound healing assays after treatment with LIFR-AS1 mimics or siLIFR-AS1. (B) Breast cancer cell invasion was analyzed by transwell invasion assays after treatment with LIFR-AS1 mimics or siLIFR-AS1. **P<0.01, ***P<0.001.